The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Cancer Drug News FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf for HER2-positive breast cancer July 2, 2020 The Food and Drug Administration (FDA) approved a new fixed-dose combination of pertuzumab, trastuzumab, and…